Retraction Note to: EuroFlow-Based Next-Generation Flow Cytometry for Detection of Circulating Tumor Cells and Minimal Residual Disease in Multiple Myeloma.

The authors have used the EuroFlow methods for many years (EuroFlow membership since 2013) and have built extensive experience with the application of these methods, they did not contribute to the design and standardization of the EuroFlow methods. Other members of the EuroFlow consortium have developed and standardized the methods and tools over a period of more than 6 years (2006-2012). These EuroFlow members have not been informed about the writing of the book chapter and have not been acknowledged as the original designers of the presented methods.